@article{oai:shiga-med.repo.nii.ac.jp:00004011,
 author = {花田, 哲郎 and 木村, 文則 and 北澤, 純 and 森宗, 愛菜 and 村上, 節 and HANADA, Tetsuro and KIMURA, Fuminori and KITAZAWA, Jun and MORIMUNE, Aina and MURAKAMI, Takashi},
 journal = {The journal of obstetrics and gynaecology research},
 month = {Oct},
 note = {pdf, Postoperative hormone therapy for hormone-sensitive patients with breast cancer is important to prevent a recurrence. As hormone therapy does not induce infertility in patients, fertility-preserving therapy is not provided during treatment. Here, however, we performed controlled ovarian stimulation and embryo freezing for fertility preservation under the influence of a sustained-release gonadotropin-releasing hormone agonist in a patient with breast cancer whose postoperative treatment plan was changed from hormone therapy to chemotherapy. After oocyte retrieval, the patient developed treatment-resistant severe symptomatic ovarian hyperstimulation syndrome. Following treatment with oral gonadotropin-releasing hormone antagonist, her symptoms immediately improved, and she could receive chemotherapy on schedule., Journal Article},
 title = {Impact of an oral gonadotropin-releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained-release gonadotropin-releasing hormone agonist : A case report.},
 year = {2021}
}